Seagen Inc., a leading biotechnology company headquartered in the United States, is at the forefront of developing innovative cancer therapies. Founded in 1998, Seagen has made significant strides in the oncology sector, particularly in the development of antibody-drug conjugates (ADCs) that target specific cancer cells while minimising damage to healthy tissue.
With a strong presence in major operational regions including North America and Europe, Seagen's core products, such as ADCETRIS and PADCEV, are recognised for their unique mechanisms of action and efficacy in treating various types of cancer. The company has established itself as a key player in the biopharmaceutical industry, achieving notable milestones such as FDA approvals and partnerships that enhance its market position. Seagen continues to drive innovation in cancer treatment, aiming to improve patient outcomes worldwide.
+44 vs industry average
Seagen Inc.’s score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Seagen Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Seagen Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Seagen Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Seagen Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Pfizer Inc.
Carbon Disclosure Project
Inherited from Pfizer Inc.
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Pfizer Inc.
RE 100
Inherited from Pfizer Inc.
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Seagen Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project